Summary of Innovation in Life Sciences

An Emerging Markets Perspective

EIU,

Get the Report

Innovation in Life Sciences summary
Being at the forefront of scientific development requires innovation – but what does being “innovative” entail?

Rating

9 Overall

9 Importance

8 Innovation

9 Style

Recommendation

What does it take for a newcomer in the life sciences to catch up to Western European and North American players? According to this well-researched and informative analysis by The Economist Intelligence Unit, the number one requirement is innovation. Established Western players have the know-how, the resources and the experience. To catch up in the pharmaceutical race, emerging players have to find new ways to be innovative. getAbstract recommends this report to innovators in any field interested in advancing their business ventures.

In this summary, you will learn

  • How countries can become innovative in the field of life sciences,
  • Which factors drive innovation and
  • Which strategies promote innovation.
 

Summary

Developing strong, innovative companies in the life sciences sectors is a challenge due to the scientific expertise and regulations needed. Historically, North American and European companies have had an advantage. However, a few new players such as Brazil, India, China, South Korea, Costa Rica and Singapore are proving that they can also becoming leaders.

Get the key points from this report in less than 10 minutes. Learn more about our products or log in

About the Author

The Economist Intelligence Unit is the research and analysis department of The Economist Group.


Comment on this summary

More on this topic

By the same author

Customers who read this summary also read

More by category